论文部分内容阅读
1956年Bergstrand氏等在人胎儿血清中发现电泳迁移率介于白蛋白和α_1球蛋白之间的一种蛋白质,称甲胎蛋白(α—Fetoprotein简写AFP)。临床上1964年氏等首先报道原发性肝癌患者血清中有甲胎蛋白,以后不少作者进一步证实了甲胎蛋白在原发性肝癌诊断中的价值。近年来络续报道病毒性肝炎患者血清中亦可检测到甲胎蛋白。为探索肝炎患者甲胎蛋白含量
In 1956, Bergstrand et al. Found a protein whose electrophoretic mobility was between that of albumin and alpha 1 globulin in human fetal serum and called alpha-Fetoprotein abbreviation AFP. Clinically, 1964 first reported in patients with primary liver cancer serum alpha-fetoprotein, many authors later confirmed the value of alpha-fetoprotein in the diagnosis of primary liver cancer. In recent years, continued coverage of viral hepatitis patients can also be detected in the serum of alpha-fetoprotein. To explore the hepatitis A patients with alpha-fetoprotein content